- After this course the students will understand how methods for assessing value of healthcare innovations from different perspectives – during development – can contribute to more efficient and successful biomedical engineering and can support implementation in practice.
- After this course the students will understand how and when to apply health preference methods to value healthcare innovations from the perspective of the main stakeholders (for example, patients, healthcare providers, policy makers).
- After this course the students will understand how and when to apply methods to value healthcare innovations from a health and economic perspective (for example, in the context of hospitals, health insurance companies, and the Dutch healthcare system).
- After this course the students will understand how to map barriers and facilitators for implementation of a new technology, and how to create scenarios and ultimately incorporate these scenarios in a health economic model.
- Early HTA: Why is it important?
Lecturers: Erik Koffijberg, Michelle Kip, Xavier Pouwels
- Health preference elicitation: Determining what end users want
Lecturer: Janine van Til
- Health economics and modelling: Estimating technology impact
Lecturers: Erik Koffijberg, Xavier Pouwels
- Barriers & facilitators for implementation, scenario drafting.
Lecturer: Michelle Kip
The rate of biomedical innovation development is rapidly increasing. However, while many biomedical innovations may have the potential to revolutionize healthcare and the healthcare system, only a fraction of all innovations actually reach the market and (clinical) practice. This is partially caused by the strong focus on feasibility and performance during early development stages. Potential applications, expected impact on, for example, patient health outcomes and healthcare costs, and the barriers for subsequent implementation, are largely under-investigated. This course addresses the need and methods for structured early assessment of biomedical innovations during development. Particular attention is paid to methods for measuring and analysing expected health and economic outcomes, determining stakeholder preferences for health outcomes and for the process of care, and identifying barriers and facilitators for implementation in combination with scenarios for potential use. Structured application of these methods can boost the impact and value of biomedical engineering efforts by creating awareness of the context innovations are assessed and judged in, and the requirements of stakeholders that need to be met for successful future implementation.
In this course, you will work in groups of 5-6 students on a project in which you assess the potential value of a chosen innovation under development, from different perspectives. At the end, a report of the project and a presentation in the form of a corporate presentation will be graded.
End product: Report and presentation of an early Health Technology Assessment to support further R&D and anticipate on implementation in clinical practice.
The following elements should be included in your report (% of the grade of the report):
- Health/clinical need (20%)
- Preferences/conditions for use (20%)
- Expected impact/benefits of the technology (20%)
- Barriers and facilitators for actual implementation (20%)
- Discussion (10%)
- Critical reflection (lessons learned) within the project/course (10%).